Cargando…

Mcl-1 expression influcences CD8+ anti-tumor immunity.

Detalles Bibliográficos
Autores principales:	Pfannenstiel, Lukas W, Gastman, Brian R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649500/ http://dx.doi.org/10.1186/2051-1426-3-S2-P323

Ejemplares similares

Targeting immune checkpoint pathways overcomes tumor-induced CD8+ T cell suppression
por: Pfannenstiel, Lukas W, et al.
Publicado: (2014)

Tumor-induced suppressive CD8+ T cells: implications for cancer immunotherapy
por: Pfannenstiel, Lukas W, et al.
Publicado: (2013)

Mcl-1 and tumor cell persistence
por: Pfannenstiel, Lukas W., et al.
Publicado: (2014)

Tumor derived exosome induction of the CD3+CD8+ T cell tolerogenic phenotype
por: Maybruck, Brian, et al.
Publicado: (2013)

Raiding the pharmacy: genomic screening identifies known chemotherapies as negative regulators of MCL1
por: Pfannenstiel, Lukas W, et al.
Publicado: (2012)

Tumor-derived exosomes induce CD8(+) T cell suppressors
por: Maybruck, Brian T., et al.
Publicado: (2017)

Mcl-1 regulates reactive oxygen species via NOX4 during chemotherapy-induced senescence
por: Demelash, Abeba, et al.
Publicado: (2017)

Harnessing the potential of radiation treatment of brain metastases to improve melanoma immunotherapy
por: McNeilly, Corey D, et al.
Publicado: (2015)

Detection of antibody therapy-induced anti-tumor immune responses using anti-CD8 immuno-pet
por: Tavare, Richard, et al.
Publicado: (2015)

Upregulation of neuroreceptors on CD4+ and CD8+ T cells promotes their anti-tumor function
por: de Aquino, Maria Teresa, et al.
Publicado: (2015)

PD-1 blockade reverses viral infection-induced loss of anti-tumor CD8+ T cell responses
por: Huelsmann, Erica, et al.
Publicado: (2013)

MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma
por: Fu, Dechen, et al.
Publicado: (2022)

CD40 expression in renal cell carcinoma correlates with tumor apoptosis, CD8 T cell frequency and patient survival
por: Weiss, Jonathan M, et al.
Publicado: (2013)

Acute viral infection results in a PD-1-dependent loss of anti-tumor CD8+ T cell responses: implications for tumor immunotherapy
por: Kohlhapp, Frederick, et al.
Publicado: (2015)

Combination immunotherapy with anti-CTLA-4 and interleukin-2 redirects regulatory T cells into tumor-draining lymph nodes and expands anti-tumor CD8+ T cells in the tumor microenvironment
por: Broucek, Joseph, et al.
Publicado: (2014)

High frequency CD8+PD-1+ TCR clonotypes isolated from fresh melanomas display anti-tumor activity
por: Anna, Pasetto, et al.
Publicado: (2015)

Characterisation of the murine C-type lectin receptor CLECSF8 (MCL) reveals its expression on cells of the monocyte/neutrophil lineages and an inter-dependence with Mincle, but not Dectin-2
por: Kerscher, Bernhard, et al.
Publicado: (2015)

The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice
por: Mangsbo, Sara M, et al.
Publicado: (2014)

Changes in immune checkpoint protein expression on CD8 T cells during neoadjuvant therapy in patients with pancreatic cancer
por: Tsai, Susan, et al.
Publicado: (2014)

CXCR5+CD8+ T cells are localized in B cell follicles and germinal centers and exhibit regulatory and anti-tumor function
por: Chu, Fuliang, et al.
Publicado: (2015)

Cish attenuates proximal TCR-signaling and CD8+ T cell immunity
por: Palmer, Douglas, et al.
Publicado: (2014)

The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent
por: He, Li-Zhen, et al.
Publicado: (2015)

Bystander memory CD8 T cell proliferation after anti-CD40/IL-2 treatment is independent of CD4 T cells
por: Grossenbacher, Steven K, et al.
Publicado: (2013)

IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness
por: Johnson, C Bryce, et al.
Publicado: (2013)

Maturation of protective immunity induced by SIVΔnef correlates with differential expression of transcription factors in SIV-specific CD8+ T cells
por: Billingsley, JM, et al.
Publicado: (2012)

Generation and utilization of polyfunctional anti-tumor CD4+ T cells
por: Zhou, Gang, et al.
Publicado: (2015)

P01-02. Anti-inflammatory and regulatory mechanisms provide the context for an effective CD8+ T cell response in live-attenuated immunized animals
por: Ferrer, M Genescà, et al.
Publicado: (2009)

Profiling of coexpression of multiple immune checkpoints in the CD4+ and CD8+ T cell components of the clear cell renal cell carcinoma immune infiltrate
por: Monette, Anne, et al.
Publicado: (2015)

Induction of systemic anti-melanoma immunity through intratumoral TLR-7/8 activation
por: Singh, Manisha, et al.
Publicado: (2014)

CD8α+ dendritic cells dictate immune responses against murine AML
por: Kline, Douglas E, et al.
Publicado: (2013)

The impact of metabolic stress on anti-tumor immunity in laboratory mice
por: Kokolus, Kathleen M, et al.
Publicado: (2013)

Modulation of immune cell infiltrate with sunitinib to improve anti-PD1 therapy in preclinical tumor model
por: Rayman, Patricia, et al.
Publicado: (2015)

Cish actively silences tcr signaling in CD8+ T cells to maintain tumor tolerance
por: Palmer, Douglas, et al.
Publicado: (2015)

Validation and clinical correlation of triplex CD3, CD8 and FOXP3 IHC of tumor-infiltrating lymphocytes in follicular lymphoma
por: Mansfield, James, et al.
Publicado: (2014)

Bim and PD-1 identify effector CD8 T cells responsive to anti-PD-1 therapy in metastatic melanoma patients
por: Dronca, Roxana, et al.
Publicado: (2015)

Pet imaging of cytotoxic human T cells using an 89Zr-labeled anti-CD8 minibody
por: Olafsen, Tove, et al.
Publicado: (2015)

Generation of tumor antigen-specific CD4+ and CD8+ T cells by simultaneous MHC-I and -II epitope presentation in vitro and in vivo
por: Wehner, Carina, et al.
Publicado: (2014)

Downregulation of the 5’-ectonucleotidase CD73 of CD8+ CTL of HIV infected patients correlates with immune activation and diminished IL-2 production
por: Toth, I, et al.
Publicado: (2012)

Epitope optimization of a DNA vaccine targeting SSX-2 leads to PD-1 upregulation on antigen-specific CD8 T cells and PD-L1 upregulation on tumor cells
por: Rekoske, Brian, et al.
Publicado: (2013)

Adenosine regulates radiation therapy-induced anti-tumor immunity
por: Wennerberg, Erik, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hajumnbojv6lda0eor90ff9036